Evidence map›Paper›PMID 26404403›Full record

ArticleScientific reports2015

Optofluidic analysis system for amplification-free, direct detection of Ebola infection.

H Cai, J W Parks, T A Wall, M A Stott, A Stambaugh, K Alfson, A Griffiths, R A Mathies, R Carrion, J L Patterson and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Free-Space Excitation of Optofluidic Devices for Pattern-Based Single Particle Detection.IEEE photonics technology letters : a publication of the IEEE Laser and Electro-optics Society · 2021
    Article
  18. Article
  19. Article
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

H CaiSchool of Engineering, University of California Santa Cruz, 1156 High Street, Santa Cruz, CA 95064 USA.
J W ParksSchool of Engineering, University of California Santa Cruz, 1156 High Street, Santa Cruz, CA 95064 USA.
T A WallECEn Department, 459 Clyde Building, Brigham Young University, Provo, UT 84602 USA.
M A StottECEn Department, 459 Clyde Building, Brigham Young University, Provo, UT 84602 USA.
A StambaughSchool of Engineering, University of California Santa Cruz, 1156 High Street, Santa Cruz, CA 95064 USA.
K AlfsonDepartment of Virology and Immunology, Texas Biomedical Research Institute, 7620 NW Loop 410, San Antonio, TX 78227 USA.
A GriffithsDepartment of Virology and Immunology, Texas Biomedical Research Institute, 7620 NW Loop 410, San Antonio, TX 78227 USA.
R A MathiesDepartment of Chemistry, University of California Berkeley, Berkeley, CA 94720 USA.
R CarrionDepartment of Virology and Immunology, Texas Biomedical Research Institute, 7620 NW Loop 410, San Antonio, TX 78227 USA.
J L PattersonDepartment of Virology and Immunology, Texas Biomedical Research Institute, 7620 NW Loop 410, San Antonio, TX 78227 USA.
A R HawkinsECEn Department, 459 Clyde Building, Brigham Young University, Provo, UT 84602 USA.
H SchmidtSchool of Engineering, University of California Santa Cruz, 1156 High Street, Santa Cruz, CA 95064 USA.

Funding

Hybrid integrated molecular analysis (HIMAS) for point-of-care diagnosticsR33AI100229 · NIAID · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI SCHMIDT, HOLGER · 2014 to 2016
$1.7M
Hybrid integrated molecular analysis (HIMAS) for point-of-care diagnosticsR21AI100229 · NIAID · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI SCHMIDT, HOLGER · 2012 to 2013
$448k
NIAID NIH HHS 1R21AI100229NIAID NIH HHS 4R33AI100229NIAID NIH HHS R21 AI100229NIAID NIH HHS R33 AI100229
6 · The paper itself

Abstract

The massive outbreak of highly lethal Ebola hemorrhagic fever in West Africa illustrates the urgent need for diagnostic instruments that can identify and quantify infections rapidly, accurately, and with low complexity. Here, we report on-chip sample preparation, amplification-free detection and quantification of Ebola virus on clinical samples using hybrid optofluidic integration. Sample preparation and target preconcentration are implemented on a PDMS-based microfluidic chip (automaton), followed by single nucleic acid fluorescence detection in liquid-core optical waveguides on a silicon chip in under ten minutes. We demonstrate excellent specificity, a limit of detection of 0.2 pfu/mL and a dynamic range of thirteen orders of magnitude, far outperforming other amplification-free methods. This chip-scale approach and reduced complexity compared to gold standard RT-PCR methods is ideal for portable instruments that can provide immediate diagnosis and continued monitoring of infectious diseases at the point-of-care.

Indexed as

Lab-On-A-Chip DevicesMicrofluidic Analytical TechniquesEbolavirusHemorrhagic Fever, EbolaHumans

Identifiers

PMID26404403
PMCPMC4585921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.